Opportunity Information: Apply for RFA AG 20 045

The NIH grant opportunity "Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required)" (RFA-AG-20-045; CFDA 93.866) supports research aimed at improving how consistently physicians deliver recommended preventive services to older adults, using guidance from the CDC and the U.S. Preventive Services Task Force. The central focus is on building and testing interventions that are embedded in electronic health records (EHRs), with the idea that EHR-based tools can more directly influence real-world clinical workflows, raise adherence to prevention guidelines, improve care quality and patient outcomes, and, importantly, reduce inequities in preventive care.

The FOA uses a phased, milestone-driven R61/R33 structure. The first phase (R61) functions as a pilot and feasibility stage where teams are expected to use EHR data and advanced analytics, including machine learning methods where appropriate, to identify specific groups of patients who are not receiving recommended preventive services. Rather than treating underuse of prevention as a single broad problem, the goal is to segment patients into meaningful subgroups and understand the distinct barriers each group faces (for example, gaps related to access, visit patterns, documentation issues, clinician decision-making, language needs, or other social and structural factors). Researchers then design scalable, tailored intervention strategies for these identified groups, with the interventions being deliverable through or tightly integrated with the EHR (such as clinical decision support, reminders, workflow prompts, panel management tools, targeted outreach triggers, or other EHR-enabled mechanisms).

If the R61 phase demonstrates feasibility and meets predefined milestones, projects may transition to the R33 phase. The R33 is intended for implementation and evaluation through pragmatic trials, meaning studies carried out under routine care conditions to test whether the intervention actually changes preventive service delivery and related outcomes when deployed in real clinical environments. Because this FOA is explicitly labeled "Clinical Trial Required," applicants are expected to propose a study design that includes a clinical trial component, particularly in the later pragmatic implementation stage, rather than stopping at tool development or observational analyses.

A non-negotiable requirement across the application is a direct focus on health disparities. Applicants must incorporate disparity considerations into how they identify under-served or under-reached patient groups, how they design and tailor the EHR-based intervention, and how they evaluate outcomes. In practice, this means the proposed work should not only improve overall preventive service use but also address unequal uptake and outcomes among populations that experience disproportionate barriers to preventive care. The FOA is oriented toward interventions that can be scaled and sustained, so reviewers will generally be looking for approaches that can be integrated into standard clinical operations rather than one-off, labor-intensive programs.

Eligibility is broad and includes many U.S.-based organization types: state, county, and local governments; special districts; independent school districts; public and private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses); small businesses; and other eligible entities. The FOA also highlights additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, certain tribal governments other than federally recognized, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly limits foreign involvement: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.

Administratively, this is an NIH discretionary grant opportunity created on September 11, 2019, with an original closing date of November 4, 2019. The listing does not provide an award ceiling or expected number of awards in the provided text, so applicants would typically need to consult the full FOA and NIH budget guidance for funding levels, project period details, and milestone expectations. Overall, the opportunity is designed for research teams that can combine geriatric prevention priorities, EHR-based implementation strategies, data analytics for identifying unmet preventive needs, and pragmatic trial methods, while keeping equity and disparity reduction as a core objective rather than an add-on.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2019-09-11.
  • Applicants must submit their applications by 2019-11-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 20 045

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Central and Peripheral Control of Balance in Older Adults (R01 Clinical Trial Optional)

Previous opportunity: Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 20 045

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 20 045) also looked into and applied for these:

Funding Opportunity
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) Apply for RFA OD 19 027

Funding Number: RFA OD 19 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed) Apply for RFA AI 19 063

Funding Number: RFA AI 19 063
Agency: National Institutes of Health
Category: Health
Funding Amount: $600,000
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) Apply for PAR 19 374

Funding Number: PAR 19 374
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovative Programs to Enhance Research Training (IPERT) (R25 - Independent Clinical Trial Not Allowed) Apply for PAR 19 383

Funding Number: PAR 19 383
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25) Apply for PAR 19 380

Funding Number: PAR 19 380
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Projects (Collaborative U01 - Clinical Trial Not Allowed) Apply for RFA AA 20 003

Funding Number: RFA AA 20 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Research Resource (Collaborative U24 - Clinical Trial Not Allowed) Apply for RFA AA 20 005

Funding Number: RFA AA 20 005
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Consortium on the Neurobiology of Adolescent Drinking in Adulthood (NADIA) Administrative Resource (Collaborative U24 - Clinical Trial Not Allowed) Apply for RFA AA 20 004

Funding Number: RFA AA 20 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 19 028

Funding Number: RFA OD 19 028
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
The President’s Malaria Initiative: Evaluation & Research-to-Use Implementation Project Apply for GH BAA 2018 ADDENDUM04

Funding Number: GH BAA 2018 ADDENDUM04
Agency: Agency for International Development
Category: Health
Funding Amount: Case Dependent
Low Cost Detection of Cognitive Decline in Clinical Settings (R01 Clinical Trial Required) Apply for RFA AG 20 051

Funding Number: RFA AG 20 051
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33 Clinical Trial Required) Apply for RFA AG 20 050

Funding Number: RFA AG 20 050
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed) Apply for PAR 20 027

Funding Number: PAR 20 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed) Apply for PAR 20 026

Funding Number: PAR 20 026
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) Apply for PAR 19 390

Funding Number: PAR 19 390
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Service Delivery for Vulnerable Children and Adolescents (SDVCA) Apply for 72061120RFA00001

Funding Number: 72061120RFA00001
Agency: Zambia USAID-Lusaka
Category: Health
Funding Amount: $50,000,000
Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18) Apply for PA 20 028

Funding Number: PA 20 028
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed) Apply for PAR 20 029

Funding Number: PAR 20 029
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clinical Trial Not Allowed) Apply for RFA AI 19 065

Funding Number: RFA AI 19 065
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 059

Funding Number: RFA AI 19 059
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 20 045", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: